DGX rides on double-digit diagnostics growth and a wave of strategic acquisitions despite rising debt and policy headwinds.

New Jersey-based Quest Diagnostics announced it has acquired ConVerge Diagnostic Services, LLC, which operates full-services medical laboratories throughout New England. This is the fourth ...

Ahmedabad: Intas Pharma has announced the appointment of Udit Sakhuja as Senior General Manager - Global New Product Launch.

The Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare ...

Companies across all industries thrive in commercial sites that fit their preferences. Here, a look at Marlborough, MA and ...

Sonic is in a strong financial position. Free cash flow conversion of earnings before acquisition spending has averaged 94% over the last 5 years and has allowed Sonic to quickly repay the debt ...

How about we talk about the 15 players whose names have finally worn thin amongst the decision makers in NFL front offices.

Valued at a market cap of $20.1 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing, ...

A high-level overview of Quest Diagnostics Incorporated (DGX) stock. View (DGX) real-time stock price, chart, news, analysis, analyst reviews and more.

Quest Diagnostics DGX has outperformed the market over the past 5 years by 299.46% on an annualized basis producing an average annual return of 313.78%. Currently, Quest Diagnostics has a market ...

Quest will develop a blood test to detect one or more cancers, including colorectal, lung, breast, pancreatic, ovarian, liver, prostate, esophageal and stomach, based on MD Anderson technology.